Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Analysis of Clinical Benefit Using DNG64-<i>CAR-V</i> Chimeric Tumor Targeted Amphotropic RNA Vector in <i>CCNG1</i> Expressing Cancers.

Anticancer research·2026
Same author

Corrigendum <i>Methylomonas stagni</i> sp. nov., a methanotroph of the genus <i>Methylomonas</i>, from a reservoir pond in Korea.

International journal of systematic and evolutionary microbiology·2026
Same author

PomBase in 2026: expanding knowledge, modeling connections.

Genetics·2026
Same author

<i>Methylomonas stagni</i> sp. nov., a methanotroph of the genus <i>Methylomonas</i>, from a reservoir pond in Korea.

International journal of systematic and evolutionary microbiology·2025
Same author

Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients.

Cancer research communications·2025
Same author

Gene and Cell Therapy for Sarcomas: A Review.

Cancers·2025

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Paul Y Song1, Lucia Hui1, Katia Betito1

  • 1NKGen Biotech, Santa Ana, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

一种新的自然杀手 (NK) 细胞疗法Troculeucel通过清除有毒蛋白质和减少神经炎症,在阿尔茨海默病 (AD) 中显示出前景. 一期试验表明,在阿尔茨海默病患者中,安全性和潜在的认知益处.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 细胞疗法细胞疗法

背景情况:

  • 阿尔茨海默病 (AD) 涉及神经炎症,由错误折叠的蛋白质和自身反应性T细胞驱动.
  • 自然杀手 (NK) 细胞通过清除蛋白质沉积物和消除有害的T细胞提供潜在的治疗益处.
  • 托罗库卢塞尔是一种创新的,非转基因自主NK细胞产品,旨在增强细胞毒性和激活受体表达.

研究的目的:

  • 评估Troculeucel在体外对粉样蛋白和α-synuclein蛋白以及自身反应性T细胞的疗效.
  • 通过I期临床试验,评估Troculeucel在阿尔茨海默病患者的安全性和初步疗效.
  • 描述Troculeucel对关键受体 (CXCR3,DNAM-1,NKG2D) 的表达,这些受体参与向病变细胞.

主要方法:

  • 在体外测试以评估Troculeucel对与疾病相关的蛋白质和T细胞的细胞和细胞毒性能力.
  • 两个I期临床试验 (NCT04678453,NCT06189963) 用Troculeucel给阿尔茨海默病患者.
  • 监测安全性,认知功能 (ADCOMS分数) 和脑脊液 (CSF) 生物标志物 (Aβ42/40,p-tau,α-synuclein,GFAP).

主要成果:

  • 在体外,Troculeucel有效地细胞化和消化了粉样蛋白和α-synuclein蛋白质.
  • 托罗库卢塞尔显示DNAM-1 (99%) 和NKG2D的高表达,仅在自身反应性T细胞的存在下激活.
  • 一期试验显示,92.3%的患者的认知得分稳定或改善,Troculeucel穿越血脑屏障 (BBB) 并改善关键的CSF生物标志物.
  • 观察到GFAP水平的显著降低,特别是在较高剂量时,与认知能力的改善相关.

结论:

  • 来自AD患者的Troculeucel有效地穿越BBB,并准自身反应性T细胞以减轻神经炎症.
  • 该疗法改善了粉样蛋白和α-synuclein的CSF水平,这表明减少蛋白质聚合物的机制.
  • 观察到的GFAP减少与稳定或改善的认知功能相关,突出显示Troculeucel在阿尔茨海默氏症治疗中的治疗潜力.